Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

Optimal conditioning therapy for hematopoietic cell transplantation (HCT) in acute myelogenous leukemia (AML) remains undefined. We retrospectively compared outcomes of a consecutive series of 51 AML patients treated with oral busulfan (1 mg/kg every 6 hours for 4 days) and cyclophosphamide (60 mg/k...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pidala, Joseph, Kim, Jongphil, Anasetti, Claudio, Kharfan-Dabaja, Mohamed A, Nishihori, Taiga, Field, Teresa, Perkins, Janelle, Perez, Lia, Fernandez, Hugo F
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958877/
https://ncbi.nlm.nih.gov/pubmed/20925957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-3-36
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados